EP2297152 - Bibliographic data
FORME DE CRISTAL ANHYDRE DE MALÉATE D ORVÉPITANT
| Last update | 25/05/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
NERRE THERAPEUTICS LIMITED Stevenage Bioscience Catalyst
Office F25 Incubator Building
Gunnels Wood Road
Stevenage Herts
SG1 2FX
Royaume-Uni
|
|---|---|
| (72) Inventors |
Stefania BEATO GlaxoSmithKline
via Alessandro Fleming 2
I-37135 Verona
Italie
Franco SARTOR GlaxoSmithKline
via Alessandro Fleming 2
I-37135 Verona
Italie
Ian STEEPLES c/o GlaxoSmithKline
Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY
Royaume-Uni
|
| (74) Agent |
Mail recipient Cabinet MURGITROYD 165-169 Scotland Street
G5 8PL
GLASGOW
Royaume-Uni
|
| (21) Request number | EP09731234.2 |
|---|---|
| (22) Request date | 09/04/2009 |
| (11) Publication number | EP2297152 |
|---|---|
| Publication date | 12/11/2014 |
| (54) Title of the invention | FORME DE CRISTAL ANHYDRE DE MALÉATE D ORVÉPITANT |
|---|---|
| (51) International classification | C07D 487/04, A61K 31/4985, A61P 25/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 0806652 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | Annuity: 18 - Amount: 420 € - Due date 30/04/2026 |
|---|---|
| Last annuity | Annuity: 17 - Payment date 29/04/2025 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2014/51, of 19/12/2014 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 12/11/2014 Constitution de mandataire pour un dossier - Legal date 18/12/2014 Entrée en période de grâce du brevet d'invention - Legal date 03/05/2022 |